In conclusion, the compounds resulting from the presented invention have the potential to be useful in the treatment of diseases associated with the JAK/STAT pathway, including inflammatory and autoimmune disorders, as well as cancer. This evidence concerns the gene SOAT1 and autoimmune disease.